Not evaluated by SAHPRA. Research & educational information only — nothing is for sale; not intended to diagnose, treat, cure or prevent any disease.
Weight LossResearch vialGLP-1GIPWeight lossOnce weeklyDual agonist
Tirzepatide
Dual GLP-1 + GIP agonist — deeper weight loss with cleaner GI per kilo lost.
- Format
- Research vial
- Strength / pack
- 30mg vial
- Category
- Weight Loss
Dual receptor actionActivates GLP-1 and GIP receptors simultaneously for amplified metabolic effect.
Up to 20.9% lossSURMOUNT-1 reported 20.9% mean weight loss at 15 mg over 72 weeks.
Insulin sensitisationGIP arm appears to amplify insulin response and improve glucose handling.
Better GI toleranceLower side-effect burden per unit of weight loss compared with single-receptor analogs.
Tirzepatide is a synthetic dual agonist that activates both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor. The added GIP arm appears to amplify insulin sensitisation and may reduce the gastrointestinal side-effect burden per unit of weight loss. Administered subcutaneously once weekly.
More in Weight Loss
Related research
Weight LossCapsules
90 capsules
Natural Fat Burner
A daily botanical + thermogenic capsule designed to support metabolism and an active routine — from the Slender Living line.
Read the research →
Weight LossCapsules
30 capsules
S30 Extreme Fat Burner
An extreme thermogenic fat-burner capsule — formulated for serious weight-loss routines and hard-training days.
Read the research →
Weight LossCapsules
30 capsules
V30 Hardcore Fat Burner
A hardcore fat-burner capsule for advanced users — intense thermogenic support to push past plateaus.
Read the research →
Publisher
Elegant Slimming · Mokopane, Limpopo, South Africa
Research library · nothing on this site is for sale.
Regulatory
This compound has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA).
For information purposes only — not intended to diagnose, treat, cure or prevent any disease.